The results showed that mice inoculated with USP13-deficient cells evidently formed smaller tumor masses than those inoculated with control cells, and this reduction was abrogated by reconstituted expression of shRNA-resistant WT USP13 but not the catalytically inactive USP13 (C345A) mutant (Figure 2F). Here, USP13 is linked to neoplasm.